Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
Date on which the terms and conditions of the preferential rights issue were announced: 29 May 2024
Last day of trading including subscription rights: 19 June 2024
Ex-date: 20 June 2024
Record Date: 21 June 2024
Date of approval of the Rights Issue: 19 June 2024 (AGM)
Maximum number of new shares: 20,732,010
Subscription price: NOK 2.50
Ratio subscription rights: Each existing shareholder as of 19 June 2024 (and being registered as such in Euronext Securities Oslo, the Norwegian Central Securities Depository, (the VPS) as at the expiry of 21 June 2024 (the record date)) will be granted 1.945786612 subscription rights for each share registered as held by the shareholder, rounded down to the nearest whole subscription right.
Subscription ratio: 1:1 (number of new shares per subscription right)
Manager: Redeye AB
Will the rights be listed: The Company will apply for listing of the subscription rights on the Oslo Stock Exchange (ticker code: CRNAT)
ISIN for the subscription rights: ISIN NO 0013261016
Warrants: The subscribers in the Rights Issue will without additional consideration be allocated one warrant (Nw.: frittstående tegningsrett) issued by the Company for every new share subscribed for and allocated to the subscriber in the Rights Issue (the "Warrants"). The number of Warrants to be issued in the Rights Issue will be minimum 3,658,000 and maximum 20,732,010. Each Warrant will give the holder the right to subscribe for and be allocated one additional share in the Company at a subscription price equal to the higher of (i) the volume weighted average price quoted for trades in the Shares of the Company the ten last trading days on the Oslo Stock Exchange prior to commencement of the Exercise Period (as defined below) less a discount of 30% and (ii) NOK 0.60 and which may be exercised in the period from 08:00 hours (CET) on 4 December 2024 to 16:30 hours (CET) on 18 December 2024 (the "Exercise Period"). The Company may apply for listing of the Warrants on the Oslo Stock Exchange or Euronext Growth Oslo. The number of shares underlaying each Warrant and the subscription price for such shares will be adjusted for any reverse split of the shares in the Company following completion of the Rights Issue.
This information is published in accordance with the requirements of the Continuing Obligations.